Hwang, Jessica P <br/><br/>
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy.  [electronic resource] 

 -  JCO clinical cancer informatics  03 2019 
 - 1-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2473-4276 
<br/><br/><label>Standard No.: </label>10.1200/CCI.18.00097  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--adverse effects<br/>Cost-Benefit Analysis<br/>Decision Making<br/>Decision Trees<br/>Hepatitis B--diagnosis<br/>Hepatitis B virus--genetics<br/>Humans<br/>Immunosuppressive Agents--adverse effects<br/>Mass Screening<br/>Models, Theoretical<br/>Neoplasms--complications<br/>Quality of Life<br/>Quality-Adjusted Life Years<br/>SEER Program